ħ±¸°æ¶ô°úÇבּ¸¼¾ÅÍ
 
 
Home > ÇмúÈ°µ¿ > ÃÊû°­¿¬

  Understanding the molecular and genetic features of prostate cancer by transgenic mice approaches
  ÀÛ¼ºÀÚ :      ÀÛ¼ºÀÏ : 06-08-16 00:00   Á¶È¸ : 4726  
   abstractkorea.doc (20.5K)
ħ±¸°æ¶ô°úÇבּ¸¼¾ÅÍ ÃÊû°­¿¬

> ÁÖ Á¦ : Understanding the molecular and genetic features of prostate cancer by transgenic mice approaches
> ¿¬ »ç : ÀÌ»óÇö ¹Ú»ç
> ¼Ò ¼Ó : Dr. Thomas Roberts¡¯ Lab.
            Dana-Farber Cancer Institute Harvard University
> ÀÏ ½Ã : 2006. 08. 14(¿ù¿äÀÏ) p.m 16:00 ~
> Àå ¼Ò : °æÈñ´ë(¼ö¿ø) ÀüÀÚÁ¤º¸±¸°ü 442È£ ¼¼¹Ì³ª½Ç
> ÁÖ ÃÖ : °úÇбâ¼úºÎ¡¤Çѱ¹°úÇÐÀç´Ü
> ÁÖ °ü : °æÈñ´ë ħ±¸°æ¶ô°úÇבּ¸¼¾ÅÍ

> Abstract
Prostate cancer is the second death causing cancer in USA. Fundamental molecular mechanisms of the prostate cancer have been poorly understood, which has caused slow progression in developing better therapeutic and prognostic methods.  This is mostly due to lack of fundamental understandings of molecular mechanisms and a dearth of proper in vivo animal model systems. Therefore, this work is focused on creating animal models and studying molecular mechanisms in prostate cancer. Here, we induce gene expression of PI3 kinase p110 beta, Polyoma Virus middle T antigen, and luciferase in mouse prostate.  Both PI3 kinaseand PyV mT induce mouse PIN.  DNA array results display multiple pathway genes are up-/down-regulated.  In conclusion, animal models that we have created reflect the characteristic of human prostate cancer and can be used for testing the efficacy of therapeutic drugs.

The Essence of Meridian (°æ¶ôÀÇ ½ÇÁú)
Matrix metalloproteinase-3 in neurodegeneration : In pursuit of a novel neuroprotective therapy